Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial
Author:
Liana K Billings,Francesco Andreozzi,Marie Frederiksen,Pierre Gourdy,Amoolya Gowda,Linong Ji,Laura Pletsch-Borba,Ryo Suzuki,A G Unnikrishnan,André G D Vianna
Publication:
The Lancet Diabetes & Endocrinology
© 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.